About Vivoryon Therapeutics N.V.

Company Description

We are focused on developing innovative small molecule-based medicines. Driven by our passion for ground-breaking science and innovation, we strive to change the lives of patients in need suffering from severe diseases. We build on our in-depth expertise in understanding post-translational modifications to develop medicines that modulate the activity and stability of proteins which are altered in disease settings

Year founded

1997

Served area

Europe

Headquarters

Weinbergweg 22, 06120 Halle (Germany) – Netherlands

Shareholder information

Shares outstanding

24,105,278

IPO

Jan. 1, 2000

Stock exchange(s)

Euronext Amsterdam

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.